← Back to Clinical Trials
Recruiting NCT06533293

Improving Neck Control in Children With Cerebral Palsy Using Robotics

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Cerebral Palsy
Sponsor Columbia University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 11 Years
Max Age 21 Years
Start Date 2025-03-06
Completion 2026-06-30
Interventions
Neck Brace Device

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this study is to characterize the head-neck motion of children with cerebral palsy and investigate how robotics can be used to improve the head-neck coordination of these children. Aim 1 is a cross-sectional study. In this single-session, kinematic and muscle activity data will be collected during the postural static, active-proactive, and reactive postural head tasks. Gross Motor Functional Classification System (GMFCS) levels will also be collected to categorize the sample into subgroups. Aim 2 is a prospective cohort quasi-experimental study. The data will be collected at baseline, across 12 intervention sessions, 1 week post-intervention, and 3 months follow-up. Functional assessments will be used to compare across the pre, mid, and post training. Participants will be assessed in Gross Motor Functional Measures (GMFM), Seated Posture and Reaching Control (SP\&R-co), and Canadian Occupational and Performance Measure (COPM). The primary outcomes will be SP\&R-co test and COPM pre- and post-intervention.

Eligibility Criteria

Inclusion Criteria: * CP, as medical diagnosis * GMFCS IV-V classification Exclusion Criteria: * severe cognitive deficits * uncontrolled epilepsy * severe dyskinesia * spinal cord malformations * severe vertebral column deformities (scoliosis \>40° and/or kyphosis \>45º) * blindness * chemo-denervation 3 months before study

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}